(Q46480923)
Statements
1 reference
Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy (English)
1 reference
D Maitland
1 reference
A Jackson
1 reference
J Osorio
1 reference
S Mandalia
1 reference
B G Gazzard
1 reference
G J Moyle
1 reference
Epivir-Ziagen (EZ) Switch Study Team
1 reference
8 July 2008
1 reference
1 reference
9
1 reference
8
1 reference
667-672
1 reference
Identifiers
1 reference